$LTBR
LIGHTBRIDGE Corp

2024 Q2 Form 10-Q Financial Statement

#000147793224002689 Filed on May 10, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q1
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.793M $2.158M $1.866M
YoY Change 12.04% 15.64% -2.49%
% of Gross Profit
Research & Development $909.6K $1.024M $448.0K
YoY Change 147.95% 128.51% 70.47%
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $2.702M $3.182M $2.314M
YoY Change 37.61% 37.49% 6.32%
Operating Profit -$2.702M -$3.182M -$2.283M
YoY Change 37.61% 39.36% 11.2%
Interest Expense $327.6K $362.0K $256.4K
YoY Change 12.96% 41.19% 7203.99%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$2.375M -$2.820M -$2.027M
YoY Change 42.0% 39.13% -1.12%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$2.375M -$2.820M -$2.027M
YoY Change 42.0% 39.13% -1.12%
Net Earnings / Revenue
Basic Earnings Per Share -$0.17
Diluted Earnings Per Share -$0.17 -$0.21 -$0.17
COMMON SHARES
Basic Shares Outstanding 14.43M shares 13.94M shares 12.13M shares
Diluted Shares Outstanding 13.49M shares 11.67M shares

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $27.07M $27.94M $28.05M
YoY Change -4.03% -0.39% -0.62%
Cash & Equivalents $27.07M $27.94M $28.05M
Short-Term Investments
Other Short-Term Assets $302.7K $401.9K $393.4K
YoY Change -14.89% 2.14% -29.59%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $27.37M $28.34M $28.44M
YoY Change -4.17% -0.35% -1.18%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $476.3K $479.6K $345.0K
YoY Change -2.76% 39.02%
Total Long-Term Assets $585.1K $588.5K $453.2K
YoY Change -2.15% 29.84% 346.18%
TOTAL ASSETS
Total Short-Term Assets $27.37M $28.34M $28.44M
Total Long-Term Assets $585.1K $588.5K $453.2K
Total Assets $27.95M $28.93M $28.90M
YoY Change -4.13% 0.12% 0.04%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $232.8K $207.4K $176.0K
YoY Change 151.11% 17.87% 75.98%
Accrued Expenses $700.0K $700.0K $400.0K
YoY Change 40.0% 75.0% 300.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $932.8K $907.4K $576.0K
YoY Change 57.38% 57.54% 27.2%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $932.8K $907.4K $576.0K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $932.8K $907.4K $576.0K
YoY Change 57.38% 57.54% 27.2%
SHAREHOLDERS EQUITY
Retained Earnings -$157.6M -$155.2M -$146.5M
YoY Change 6.35% 5.94%
Common Stock $14.59K $14.19K $12.13K
YoY Change 16.87% 17.02%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $27.02M $28.03M $28.32M
YoY Change
Total Liabilities & Shareholders Equity $27.95M $28.93M $28.90M
YoY Change -4.13% 0.12% 0.04%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q1
OPERATING ACTIVITIES
Net Income -$2.375M -$2.820M -$2.027M
YoY Change 42.0% 39.13% -1.12%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$1.847M -$1.878M -$1.580M
YoY Change 29.14% 18.88% -18.3%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 972.1K $1.222M $731.1K
YoY Change -38.61% 67.15% -86.49%
NET CHANGE
Cash From Operating Activities -1.847M -$1.878M -$1.580M
Cash From Investing Activities 0.000 $0.00 $0.00
Cash From Financing Activities 972.1K $1.222M $731.1K
Net Change In Cash -875.4K -$656.0K -$848.7K
YoY Change -673.19% -22.7% -124.39%
FREE CASH FLOW
Cash From Operating Activities -$1.847M -$1.878M -$1.580M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Accounts Payable Trade Current And Noncurrent
AccountsPayableTradeCurrentAndNoncurrent
200000 usd
CY2023Q4 us-gaap Accounts Payable Trade Current And Noncurrent
AccountsPayableTradeCurrentAndNoncurrent
100000 usd
CY2024Q1 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
500000 usd
CY2023Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
400000 usd
CY2024Q1 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
900000 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
500000 usd
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001084554
CY2024Q1 dei Amendment Flag
AmendmentFlag
false
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000 shares
CY2023Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
24000 usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0 pure
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0 pure
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity File Number
EntityFileNumber
001-34487
CY2024Q1 dei Entity Registrant Name
EntityRegistrantName
LIGHTBRIDGE CORPORATION
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2024Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
91-1975651
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
11710 Plaza America Drive
CY2024Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 2000
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Reston
CY2024Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
VA
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
20190
CY2024Q1 dei City Area Code
CityAreaCode
571
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
730-1200
CY2024Q1 dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value
CY2024Q1 dei Trading Symbol
TradingSymbol
LTBR
CY2024Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
14434480 shares
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
27942421 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
28598445 usd
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
401859 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
207063 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
28344280 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
28805508 usd
CY2024Q1 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
479625 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
483000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
108865 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
108865 usd
CY2024Q1 us-gaap Assets
Assets
28932770 usd
CY2023Q4 us-gaap Assets
Assets
29397373 usd
CY2024Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
907421 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
486326 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
907421 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
486326 usd
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14189780 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13698274 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
14190 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
13698 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
183228519 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
181295125 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-155217360 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-152397776 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
28025349 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
28911047 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
28932770 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
29397373 usd
CY2024Q1 us-gaap Revenues
Revenues
0 usd
CY2023Q1 us-gaap Revenues
Revenues
0 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2157745 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1865929 usd
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1023823 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
448044 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
3181568 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
2313973 usd
CY2024Q1 ltbr Contributed Services Research And Development
ContributedServicesResearchAndDevelopment
0 usd
CY2023Q1 ltbr Contributed Services Research And Development
ContributedServicesResearchAndDevelopment
31028 usd
CY2024Q1 us-gaap Other Operating Income
OtherOperatingIncome
0 usd
CY2023Q1 us-gaap Other Operating Income
OtherOperatingIncome
31028 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-3181568 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2282945 usd
CY2024Q1 us-gaap Interest Income Other
InterestIncomeOther
361984 usd
CY2023Q1 us-gaap Interest Income Other
InterestIncomeOther
256365 usd
CY2024Q1 us-gaap Other Income
OtherIncome
361984 usd
CY2023Q1 us-gaap Other Income
OtherIncome
256365 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2819584 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2026580 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-2819584 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-2026580 usd
CY2024Q1 ltbr Earnings Per Shares Basic And Diluted
EarningsPerSharesBasicAndDiluted
-0.21
CY2023Q1 ltbr Earnings Per Shares Basic And Diluted
EarningsPerSharesBasicAndDiluted
-0.17
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13491954 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11673736 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
29118155 usd
CY2023Q1 ltbr Shares Issued Registered Offerings Net Of Offering Costs Amount
SharesIssuedRegisteredOfferingsNetOfOfferingCostsAmount
731052 usd
CY2023Q1 ltbr Shares Issued To Consultant Directors For Services Amount
SharesIssuedToConsultantDirectorsForServicesAmount
215000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation Forfeited
StockIssuedDuringPeriodValueShareBasedCompensationForfeited
284360 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-2026580 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
28321987 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
28911047 usd
CY2024Q1 ltbr Shares Issued Registered Offerings Net Of Offering Costs Amount
SharesIssuedRegisteredOfferingsNetOfOfferingCostsAmount
1221982 usd
CY2024Q1 ltbr Shares Issued To Consultant Directors For Services Amount
SharesIssuedToConsultantDirectorsForServicesAmount
255000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation Forfeited
StockIssuedDuringPeriodValueShareBasedCompensationForfeited
456904 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-2819584 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
28025349 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-2819584 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-2026580 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
456904 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
284360 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-194796 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-278173 usd
CY2024Q1 ltbr Increase Decrease In Prepaid Project Costs And Other Long Term Assets
IncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets
3375 usd
CY2023Q1 ltbr Increase Decrease In Prepaid Project Costs And Other Long Term Assets
IncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets
0 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
676095 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
440647 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1878006 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1579746 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1221982 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
731052 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1221982 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
731052 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-656024 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-848694 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
28598445 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
28899997 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
27942421 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
28051303 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2024Q1 ltbr Payment Of Accrued Liabilities With Common Stock
PaymentOfAccruedLiabilitiesWithCommonStock
255000 usd
CY2023Q1 ltbr Payment Of Accrued Liabilities With Common Stock
PaymentOfAccruedLiabilitiesWithCommonStock
215000 usd
CY2024Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company will need additional funding and /or in-kind support via a combination of strategic alliances, government grants, further offerings of equity securities, or an offering of debt securities in order to support its future research and development (R&amp;D) activities required to further enhance and complete the development and commercialization of its fuel products.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">There can be no assurance that the Company will be able to successfully continue to conduct its operations if there is a lack of financial resources available in the future to continue its fuel development activities, and a failure to do so would have a material adverse effect on the Company’s future R&amp;D activities, financial position, results of operations, and cash flows. Also, the success of the Company’s operations will be subject to other numerous contingencies, some of which are beyond management’s control. These contingencies include general and regional economic conditions, contingent liabilities, potential competition with other nuclear fuel developers, including those entities developing accident tolerant fuels, changes in government regulations, risks related to the R&amp;D of our nuclear fuel, regulatory approval of the Company’s fuel, support for nuclear power, changes in accounting and taxation standards, inability to achieve overall short-term and long-term R&amp;D milestones toward commercialization, future impairment charges to the Company’s assets, and global or regional catastrophic events. The Company may also be subject to various additional political, economic, and other uncertainties.</p>
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Period Increase Decrease
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease
555582 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Period Increase Decrease
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease
525903 shares
CY2024Q1 us-gaap Restricted Stock Shares Issued Net Of Shares For Tax Withholdings
RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings
557688 shares
CY2023Q1 us-gaap Restricted Stock Shares Issued Net Of Shares For Tax Withholdings
RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings
416316 shares
CY2024Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1113270 shares
CY2023Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
942219 shares
CY2024Q1 us-gaap Accrued Bonuses Current And Noncurrent
AccruedBonusesCurrentAndNoncurrent
200000 usd
CY2023Q4 us-gaap Accrued Bonuses Current And Noncurrent
AccruedBonusesCurrentAndNoncurrent
0 usd
CY2024Q1 ltbr Contractual Commitments
ContractualCommitments
3500000 usd
CY2023 ltbr Contractual Commitments
ContractualCommitments
3600000 usd
CY2024Q1 ltbr Project Task Tatement Postemployment Obligations
ProjectTaskTatementPostemploymentObligations
3100000 usd
CY2024Q1 ltbr Lessee Operating Lease Term
LesseeOperatingLeaseTerm
P12M
CY2024Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
8000 usd
CY2024Q1 ltbr Lease Payment Under Non Cancellable Operating Leases
LeasePaymentUnderNonCancellableOperatingLeases
100000 usd
CY2024Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
24000 usd
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14189780 shares
CY2024Q1 ltbr Outstanding Restricted Stock Awards
OutstandingRestrictedStockAwards
557688 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Period Increase Decrease
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease
555582 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
542972 shares
CY2024Q1 ltbr Common Stock And All Common Stock Equivalents
CommonStockAndAllCommonStockEquivalents
14745362 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13698274 shares
CY2023Q4 ltbr Outstanding Restricted Stock Awards
OutstandingRestrictedStockAwards
557688 shares
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Period Increase Decrease
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease
510787 shares
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
498177 shares
CY2023Q4 ltbr Common Stock And All Common Stock Equivalents
CommonStockAndAllCommonStockEquivalents
14209061 shares
CY2021Q1 ltbr At The Market Offerings Disclosure Description
AtTheMarketOfferingsDisclosureDescription
On March 25, 2021, the Company filed a shelf registration statement on Form S-3, registering the sale of up to $75.0 million of the Company’s securities, which registration statement was declared effective on April 5, 2021 and was set to expire on April 5, 2024. On April 4, 2023, the Company filed a prospectus supplement pursuant to which the Company could offer and sell shares of its common stock having an aggregate offering price of up to $17.9 million, of which $7.0 million remained available for future share issuances as of March 31, 2024
CY2024Q1 ltbr Proceed From Sale Of Available For Sale Securities
ProceedFromSaleOfAvailableForSaleSecurities
75000000.0 usd
CY2024Q1 ltbr Proceeds From Sale Of Available For Sale Securities B8
ProceedsFromSaleOfAvailableForSaleSecuritiesB8
6600000 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.7536 pure
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0454 pure
CY2024Q1 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
0 usd
CY2023Q1 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
0 usd
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P2Y
CY2024Q1 us-gaap Share Price
SharePrice
2.62
CY2023Q1 us-gaap Share Price
SharePrice
0
CY2024Q1 us-gaap Other Research And Development Expense
OtherResearchAndDevelopmentExpense
100000 usd
CY2023Q1 us-gaap Other Research And Development Expense
OtherResearchAndDevelopmentExpense
0 usd
CY2024Q1 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
400000 usd
CY2023Q1 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
300000 usd
CY2024Q1 us-gaap Dividends Sharebased Compensation Stock
DividendsSharebasedCompensationStock
500000 usd
CY2023Q1 us-gaap Dividends Sharebased Compensation Stock
DividendsSharebasedCompensationStock
300000 usd

Files In Submission

Name View Source Status
0001477932-24-002689-index-headers.html Edgar Link pending
0001477932-24-002689-index.html Edgar Link pending
0001477932-24-002689.txt Edgar Link pending
0001477932-24-002689-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
ltbr-20240331.xsd Edgar Link pending
ltbr_10q.htm Edgar Link pending
ltbr_ex101.htm Edgar Link pending
ltbr_ex101img19.jpg Edgar Link pending
ltbr_ex101img20.jpg Edgar Link pending
ltbr_ex101img21.jpg Edgar Link pending
ltbr_ex101img22.jpg Edgar Link pending
ltbr_ex101img23.jpg Edgar Link pending
ltbr_ex101img24.jpg Edgar Link pending
ltbr_ex101img25.jpg Edgar Link pending
ltbr_ex101img26.jpg Edgar Link pending
ltbr_ex101img27.jpg Edgar Link pending
ltbr_ex11.htm Edgar Link pending
ltbr_ex311.htm Edgar Link pending
ltbr_ex312.htm Edgar Link pending
ltbr_ex32.htm Edgar Link pending
ltbr_ex51.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
ltbr-20240331_cal.xml Edgar Link unprocessable
ltbr-20240331_def.xml Edgar Link unprocessable
ltbr-20240331_lab.xml Edgar Link unprocessable
ltbr-20240331_pre.xml Edgar Link unprocessable
ltbr_10q_htm.xml Edgar Link completed
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending